ATM and colorectal carcinoma: To elucidate how DNA damage repair is activated in oxaliplatin-treated CRC cells with or without hnRNP L knockdown, we examined and quantitative analyzed the protein expression and phosphorylation levels of ATM, BRCA1, 53BP1 and other reapair factors (Fig. 4c, d).